MedPath

Nanjing Shihejiyin Technology, Inc.

πŸ‡¨πŸ‡³China
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

The Jinling Cohort

Recruiting
Conditions
Cancer
Liquid Biopsy
Multi Cancer Early Screening
First Posted Date
2023-08-25
Last Posted Date
2023-08-25
Lead Sponsor
Nanjing Shihejiyin Technology, Inc.
Target Recruit Count
15000
Registration Number
NCT06011694
Locations
πŸ‡¨πŸ‡³

Nanjing Jiangbei People's Hospital, Nanjing, Jiangsu, China

πŸ‡¨πŸ‡³

The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.